Geneos Wealth Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-200
| Closed | -$628 | – | 2092 |
|
|
2022
Q4 | $628 | Hold |
200
| – | – | ﹤0.01% | 2005 |
|
|
2022
Q3 | $0 | Hold |
200
| – | – | ﹤0.01% | 2498 |
|
|
2022
Q2 | $0 | Hold |
200
| – | – | ﹤0.01% | 2768 |
|
|
2022
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 2689 |
|
|
2021
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 2708 |
|
|
2021
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 2783 |
|
|
2021
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 2681 |
|
|
2021
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 2927 |
|
|
2020
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 2721 |
|
|
2020
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 2565 |
|
|
2020
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 2503 |
|
|
2020
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 2416 |
|
|
2019
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 2497 |
|
|
2019
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 2435 |
|
|
2019
Q2 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 2332 |
|
|
2018
Q4 | – | Sell |
-500
| Closed | -$8K | – | 2471 |
|
|
2018
Q3 | $8K | Sell |
500
-1,000
| -67% | -$16K | ﹤0.01% | 1932 |
|
|
2018
Q2 | $21K | Buy |
1,500
+251
| +20% | +$3.51K | ﹤0.01% | 1429 |
|
|
2018
Q1 | $23K | Sell |
1,249
-1,520
| -55% | -$28K | ﹤0.01% | 1337 |
|
|
2017
Q4 | $45K | Sell |
2,769
-196
| -7% | -$3.19K | ﹤0.01% | 1049 |
|
|
2017
Q3 | $44K | Buy |
+2,965
| New | +$44K | ﹤0.01% | 1012 |
|